MELBOURNE, Fla.–(BUSINESS WIRE)–Sun Nuclear, a Mirion Medical company, today announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technical experts and clinical partners for interoperability with the company’s new radiotherapy system, Accela. Unveiled at the annual ASTRO conference, Accela is the first software-driven delivery system engineered for NeoArc (Dynamic Modulated Arc Therapy, DMAT), a new treatment technique that accelerates how radia

MONTREAL, Sept. 27, 2026 (GLOBE NEWSWIRE) — WSP Global Inc., one of the world’s leading engineering, science and infrastructure solutions firms, announces that its Power & Energy event, originally planned to be held in New York City, will instead be conducted entirely virtually due to anticipated weather conditions.

The event is still scheduled for Monday, September 28, 2026, and may be accessed via live webcast at 9:00 a.m. ET.

Registration is open through https://www.wsp.com/en-gl/investors. A replay will be available after the event in the Investors section of wsp.com.

About WSP
WSP is one of the world’s leading engineering, science and infrastructure solutions firms, uniting its multidisciplinary expertise to shape communities to advance humanity. From local beginnings to a globe-spanning presence today, WSP operates in over 50 countries and employs approximately 83,000 professionals, known as Visioneers. Together, they pioneer solutions and deliver innovative projects in the transportation, infrastructure, environment, building, energy, water, mining, and metals sectors. WSP is publicly listed on the Toronto Stock Exchange (TSX: WSP).

For more information, please contact:
Quentin Weber
Global Head, Investor Relations
+1 438-843-7519
Quentin.Weber@wsp.com

MONTREAL, Sept. 27, 2026 (GLOBE NEWSWIRE) — WSP Global Inc., one of the world’s leading engineering, science and infrastructure solutions firms, announces that its Power & Energy event, originally planned to be held in New York City, will instead be conducted entirely virtually due to anticipated weather conditions.

The event is still scheduled for Monday, September 28, 2026, and may be accessed via live webcast at 9:00 a.m. ET.

Registration is open through https://www.wsp.com/en-gl/investors. A replay will be available after the event in the Investors section of wsp.com.

About WSP
WSP is one of the world’s leading engineering, science and infrastructure solutions firms, uniting its multidisciplinary expertise to shape communities to advance humanity. From local beginnings to a globe-spanning presence today, WSP operates in over 50 countries and employs approximately 83,000 professionals, known as Visioneers. Together, they pioneer solutions and deliver innovative projects in the transportation, infrastructure, environment, building, energy, water, mining, and metals sectors. WSP is publicly listed on the Toronto Stock Exchange (TSX: WSP).

For more information, please contact:
Quentin Weber
Global Head, Investor Relations
+1 438-843-7519
Quentin.Weber@wsp.com

The Accela radiotherapy solution is engineered around NeoArc dynamic modulated arc therapy (DMAT), a breakthrough technique combining speed and precision

Boston, Sept. 27, 2026 (GLOBE NEWSWIRE) — Siemens Healthineers introduces Accela, the first radiotherapy system that allows for single breath-hold stereotactic treatments and enables multi-site SBRT treatment in as little as 60 seconds, significantly shortening patient time on the treatment table and the course of treatment. 

Contact Info

Julie Gibson
julie.gibson@siemens-healthineers.com
+1 917-929-5779

Attachment

ABU DHABI, Vereinigte Arabische Emirate–(BUSINESS WIRE)–„Future Health – A Global Initiative by Abu Dhabi“ rief am Rande der 81. Tagung der Generalversammlung der Vereinten Nationen (UNGA 81) in New York Minister, hochrangige Regierungsvertreter und führende Gesundheitsvertreter zusammen. Die hochrangige Gesprächsrunde zeigte konkrete Prioritäten für den Wandel von Gesundheitssystemen auf, weg von reaktiver Behandlung und hin zu Risikovorhersage, Prävention und früheren Interventionen. Unter

More than 25 imaging and machine QA tests in one setup.

Louvain-la-Neuve, Belgium, 27 September 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global provider of dosimetry and quality assurance (QA) solutions, today announces the launch of the QUASAR®1 Penta-Guide Performance Phantom. Designed for modern radiotherapy workflows, the new phantom enables more than 25 imaging and machine QA tests to be performed in a single setup. By consolidating multiple QA procedures in one phantom, it helps clinics reduce setup requirements, standardize workflows and support consistent routine quality assurance.

In radiation therapy, quality assurance is a critical safeguard that ensures increasingly complex treatments are delivered exactly as planned. As image-guided and adaptive radiotherapy workflows continue to evolve, clinics require QA tools that support the full process.

The QUASAR Penta‑Guide Performance Phantom combines a broad range of imaging and machine QA checks with integrated analysis software. By reducing the need for multiple phantoms, repeated setups and separate analysis tools, the system accelerates QA workflows, helps minimize procedural variability and supports more consistent testing.

Designed for image-based and machine QA testing using 2D and 3D imaging, the phantom supports consistent monitoring of image quality, geometric accuracy and system performance. Its advanced technology components support QA for image-guided and CBCT-based adaptive radiotherapy workflows. Integrated software supports DICOM handling, automated data analysis, report generation and performance trending. This reduces manual analysis and facilitates consistent documentation and longitudinal monitoring of QA results.

Jean‑Marc Bothy, President of IBA Dosimetry, said: “The QUASAR Penta-Guide Performance Phantom was developed around the realities of modern clinical workflows. By bringing imaging and machine QA checks into one setup, it helps clinical teams work more efficiently while maintaining the consistency and confidence required for image-guided and adaptive radiotherapy. In line with IBA’s mission, this new phantom supports safer treatment delivery while helping clinics save time and enabling more patients to access high-quality care.”

The unique QUASAR Penta-Guide Performance Phantom expands IBA Dosimetry’s QUASAR portfolio and is designed for routine as well as advanced imaging, machine and adaptive treatment QA in radiotherapy departments.

***ENDS***

About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as one of the most advanced forms of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,300 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
For further information, please contact:

Thomas Pevenage
Head of Investor Relations
+32 10 475 890
investorrelations@iba-group.com
Nathalie van Ypersele
Head of Communication and Sustainability
 
Daniel Ernult 
Corporate Communication Manager
+32 10 475 890
communication@iba-group.com


1 QUASAR is a trademark registered in the name of IBA Dosimetry GmbH in the European Union, the United Kingdom, Canada, and the United States.

Attachment

阿聯阿布達比–(BUSINESS WIRE)–(美國商業資訊)– 第15屆聯合國預防犯罪和刑事司法大會——2026年阿布達比大會今日在阿布達比ADNEC中心正式開幕。本次大會將持續至10月1日,吸引來自97個以上國家的代表參會,其中包括超過32位司法部長和內政部長,以及來自世界各地的高層官員、法官、檢察官、專家和年輕人代表。 開幕式上通過了《阿布達比宣言》,該宣言是本次大會最重要的政治和策略成果文件,將指導未來五年在預防犯罪、刑事司法和法治領域的國際優先事項及合作。 該宣言圍繞四大支柱展開:預防與韌性、司法與法治、不斷演變且相互交織的犯罪威脅,以及創新與合作。這四大支柱體現在18條、67個段落中,共同構成了《阿布達比宣言》。 在宣言中,阿拉伯聯合大公國宣導的優先事項包括婦女、兒童、人工智慧和環境。該宣言還涉及以下問題:組織型犯罪和網路犯罪、在刑事司法中負責任地使用人工智慧和現代技術、保護受害人、證人和弱勢群體、追回資產和打擊非法資金流動、反腐敗工作、國際合作和司法互助、引渡、婦女參與刑事司法體系、打擊針對婦女的暴力行為,以及強化對兒童需求敏感的司法體系。 開幕式代表Pledge4

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.